PROCEPT BioRobotics Corporation reports results for the quarter ended September 30 - Earnings Summary

• PROCEPT BioRobotics Corporation reported a quarterly adjusted loss of 46 cents​​ per share for the quarter ended September 30, lower than the same quarter last year, when the company reported EPS of -38 cents. The mean expectation of fifteen analysts for the quarter was for a loss of 39 cents per share. Wall Street expected results to range from -42 cents to -34 cents per share.

• Revenue rose 18% to $98.29 million from a year ago; analysts expected $102.56 million.

• PROCEPT BioRobotics Corporation's reported EPS for the quarter was a loss of 46 cents​.

• The company reported a quarterly loss of $26.52 million.

• PROCEPT BioRobotics Corporation shares had risen by 10.7% this quarter and lost 35.9% so far this year.

FORECAST CHANGES

• The mean earnings estimate of analysts had fallen by about 2.2% in the last three months.​

• In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.

RECOMMENDATIONS

• The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 5 "strong buy" or "buy," 9 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is "buy."

• Wall Street's median 12-month price target for PROCEPT BioRobotics Corporation is $22.00, about 8.3% above its last closing price of $20.17

This summary was machine generated from LSEG data November 4 at 10:44 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)